An analysis of HIV-1-associated inflammatory products in brain tissue of humans and SCID mice with HIV-1 encephalitis

Journal of NeuroVirology

Volumn 3, Issue 6, 1997, Pages 401-416

  Persidsky, Yuri ^a   Buttini, Manuel ^b   Limoges, Jenae ^a   Bock, Paul ^a   Gendelman, Howard E ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Animal model; HIV encephalitis; Inflammatory products; Neuronal damage; Neurotoxins

Indexed keywords

CD14 ANTIGEN; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MICROTUBULE ASSOCIATED PROTEIN 2; SECRETORY PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CLINICAL ARTICLE; DEMENTIA; DENDRITE; ENCEPHALITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LASER MICROSCOPY; MACROPHAGE; MICROGLIA; MONONUCLEAR PHAGOCYTE; NERVE INJURY; NEUROTOXICITY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCID MOUSE; VIRUS ENCEPHALITIS; VIRUS REPLICATION;

EID: 0031447215     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289709031186     Document Type: Article

References (49)

1. Adamson CD, Wildemann B, Sasaki M, Glass JD, McArthur JC, Christov VI, Dawson TM, Dawson VL (1996). Immunologic NO synthetase: Elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 274: 1917-1921.
2. Anders KH, Guerra WF, Tomiyasu U, Verity MA, Vinters HV (1986). The neuropathology of AIDS: UCLA experience and review. Am J Pathol 124: 537-558.
3. Brew BJ, Rosenblum M, Cronin K, Price RW (1995). AIDS dementia complex and HIV-1 brain infection: Clinical-virological correlations. Ann Neurol 38: 563-570.
4. Budka H (1986). Multinucleated giant cells in brain: a hallmark of the acquired immune deficiency syndrome (AIDS). Acta Neuropathol (Berl) 69: 253-258.
5. Bukrinsky M, Nottet HSLM, Schmidtmayerova H, Dubrovsky L, Flanagan CR, Mullins ME, Lipton SA, Gendelman HE (1995).Regulationofnitricoxidesynthaseactivityinhuman immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease.J Exp Med 181:735-745.
6. Chao CC, Hu S, Close K, Choi CS, Molitor TW, Novick WJ and Peterson PK. (1992). Cytokine release by microglia: Differential inhibition by pentoxifylllin and dexamethasone. J Inf Dis. 166: 847-853.
7. Dawson VL, Dawson TM, Uhl GR, Snyder SH (1993). Human immunodeficiency virus-1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc Natl Acad Sci USA 90: 3256-3259.
8. Gelbard HA, Nottet HSLM, Swindells S, Jett M, Dzenko KA, Genis P, White R, Wang L, Choi Y-B, Zhang D, Lipton SA, Tourtellotte WW, Epstein LG, Gendelman HE (1994). Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol 68: 4628-4635.
9. Gendelman HE, Orenstein JM, Martin MA, Ferruca C, Mitra R, Phipps T, Wahl LA, Lane HC, Fauci SD, Burke DS, Skillman DR, Meltzer MS (1988). Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med 167: 1498-1506.
10. Gendelman HE, Persidsky Y, Ghorpade A, Limoges J, Stins M, Fiala M, Morrisett R (1997). The neuropathogenesis of HIV-1 dementia. AIDS 11 suppl. A): S35-45.
11. Genis P, Jett M, Bernton EW, Boyle T, Gelbard HA, Dzenko K, Keane RW, Resnick L, Mizrachi Y, Volsky DJ, Epstein LG, Gendelman HE (1992). Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interations: implications for the neuropathogenesis of HIV disease. J Exp Med 176: 1703-1718.
12. Giulian D, Wendt E, Vaca K, Noonan CA (1993). The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc Natl Acad Sci USA 90: 2769-2773.
13. Glass JD, Wesselingh SL, Seines OA, McArthur JC (1993). Clinical and neuropathologic correlation with HIV-associated dementia. Ann Neurol 33: 2230-2237.
14. Griffin DE, Wesselingh SL, McArthur JC (1994). Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Ann Neurol 35: 592-599.
15. Kalter DC, Nakamura M, Turpin JA, Baca LM, Dieffenbach C, Ralph P, Gendelman HE, Meltzer MS (1991). Enhanced HIV replication in MCSF-treated monocytes. J Immunol 146: 298-307.
16. Kieburtz K, Schiffer RB (1989). Neurological manifestations of human immunodeficiency virus infections. Neurol Clin 7: 447-468.
17. Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, Yungbluth M, Janotta F, Aksamit A, Martin MA, Fauci AS (1986). Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233: 1089-1093.
18. Koka P, He K, Zack JA, Kitchen S, Peacock W, Fried I, Tran T, Yashar SS, Marrill JE (1995). Human immunodeficiency virus 1 envelope proteins induce interleukin-1, tumor necrosis factor-α, and nitric oxide in glial cultures derived from fetal, neonatal and adult human brain. J Exp Med 182: 941-952.
19. Korber BTM, Kunstman KJ, Patterson BK, Furtado M, McEvilly MM, Levy R, Wolinsky SM (1994). Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type-1 infected patients: Evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J Virol 68: 7467-7481.
20. Lipton SA (1992). Requirement for macrophages in neuronal injury induced by HIV envelope protein gp120. Neuroreport 3: 913-915.
21. Lipton SA (1994). Neuronal injury associated with HIV-1 and potential treatment with calcium-channel and NMDA antagonists. Dev Neurosci 16: 145-151.
22. Lipton SA, Rosenberg RA (1994). Mechanisms of disease: Excitatory animo acids as final common pathway for neurological disorders. N Engl J Med 330: 613-622.
23. Lipton SA, Gendelman HE (1995). Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 332: 934-940.
24. Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, Wiley CA (1992a). Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 32: 321-329.
25. Masliah E, Ge N, Achim CL, Hansen LA, Wiley CA (1992b). Selective neuronal vulnerability in HIV encephalitis. J Neuropathol Exp Neurol 51: 585-593.
26. Merrill JE, Martinez-Maza O (1993). Cytokines in AIDS-associated neurons and immune dysfunction. In: Neurobiology of Cytokines. Methods in Neuroscience. de Zouza EB (ed). Academic Press, San Diego: pp. 243-249.
27. Mucke L, Masliah E, Campbell IL (1995). Transgenic animal models to assess the neuropathogenic potential of HIV-1 proteins and cytokines. Curr Top Microbiol Immunol 202: 187-205.
28. Navia BA, Jordan BD, Price RW (1986a). The AIDS dementia complex. I. Clinical features. Ann Neurol 19: 517-524.
29. Navia BA, Cho E-S, Petito CK, Price RW (1986b). The AIDS dementia complex: II. Neuropathology. Ann Neurol 19: 525-535.
30. Nottett HSLM, Jett M, Flanagan CR, Zhai Q-H, Persidsky Y, Rizzino A, Bernton EW, Genis P, Baldwin T, Schwartz J, LaBenz CJ, Gendelman HE (1995). A regulatory role for astrocytes in HIV-1 encephalitis: an overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-α by activated HIV-1-infected monocytes is attenuated by primary human astrocytes. J Immunol 154: 3567-3581.
31. Parisi A, Stossell M, Pan A, Maserati R, Minoli L (1991). HIV-related encephalitis presenting as convulsant disease. Clin Electroenceph 22: 1-4.
32. Persidsky Y, Limoges J, McComb R, Bock P, Baldwin T, Tyor W, Patil A, Nottet HSM, Epstein L, Gelbard H, Flanagan E, Reinhard J, Pirruccello SJ, Gendelman HE (1996). Neuropathological analysis of HIV encephalitis in SCID mice. Am J Pathol 149: 1027-1053.
33. Peterson PK, Gekker G, Hu S, Schoolov Y, Balfour HH, Chao CC (1992). Microglial cells upregulation of HIV-1 expression in the chronically infected promonocytic cell line U1: The role of tumor necrosis factor-α. J Neuroimmunol 14: 81-88.
34. Petito CK, Cho E-S, Lemann W, Navia BA, Price RW (1986). Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. J Neuropathol Exp Neurol 45: 635-646.
35. Piani D, Spranger M, Frei K, Schaffner A, Fontana A (1992). Macrophage-induced cytotoxicity of N-methyl-D-Aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur J Immunol 22: 2429-2436.
36. Poli G, Kinter A, Justement JS (1990). Tumor necrosis factor-a functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc Natl Acad Sci USA 87: 782-785.
37. Power C, McArthur JC, Johnson RT, Griffin DE, Glass JD, Perryman S, Chesebro B (1994). Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol 68: 4643-4649.
38. Price RW, Brew B, Sidhs J, Rosenblum M, Sheck AC, Cleary P (1988a). The brain in AIDS: CNS HIV-1 infection and AIDS dementia complex. Science 239: 586-592.
39. Price RW, Sidtis J, Rosenblum M (1988b). The AIDS dementia complex: some current questions. Ann Neurol 23: S27-S33.
40. Sharer LR, Cho ES, Epstein LG (1985). Multinucleated giant cells and HTLV-III in AIDS encephalopathy. Hum Pathol 16: 760.
41. Toggas SM, Masliah E, Rockenstein EM, Rail GF, Abraham CR, Mucke L (1994). Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367: 188-193.
42. Toggas SM, Masliah E, Mucke L (1996). Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine. Brain Res 706: 303-307.
43. Tyor WR, Glass JD, Griffin JW, Becker PS, McArthur JC, Bezman L, Griffin DE (1992). Cytokine expression in the brain during the acquired immunodeficiency disease syndrome. Ann Neurol 31: 349-360.
44. Wahl LM, Corcoran ML, Pyle SW, Arthur LO, Harel-Bellan A, Farrar WL (1989). Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin-1. Proc Natl Acad Sci USA 86: 621-625.
45. Weeks BS, Lieberman DM, Johnson B (1995). Neurotoxicity of the human immunodeficiency virus type 1 tat transactivator to PC12 cells requires the tat amino acid 49-58 basic domain. J Neurosc Res 42: 34-40.
46. Wesselingh SL, Power C, Glass JD, Tylor WR, McArthur JC, Farber JM, Griffin JW, Griffin DE (1993). Intracerebral cytokine mRNA expression in AIDS. Ann Neurol 33: 576-582.
47. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MBA (1986). Cellular localization of human immunodeficiency virus infection within brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 83: 7089-7093.
48. Wiley CA, Achim C (1994). Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency disease syndrome. Ann Neurol 36: 673-676.
49. Wyss-Coray T, Masliah E, Toggas S (1996). Dysregulation of signal transduction pathways as a potential mechanism of nervous system alterations in HIV-1 gp120 transgenic mice and humans with HIV-1 encephalitis. J Clin Invest 97: 789-798.